Report Categories
View AllRecent Articles
View All
MFC Manulife reports 46 percent Q4 2025 EPS beat shares rise slightly amid sharp year over year revenue decline
NTLA Intellia Therapeutics tops Q4 2025 EPS estimates posts 169 percent yearoveryear revenue growth as shares edge slightly lower
Is Eton Pharmaceuticals ETON stock losing upward strength 184 20260420
MTSI MACOM delivers solid Q1 2026 results with 326 percent year over year revenue growth shares edge higher
The edge Sachem SCCF has in a competitive landscape Investors Pile In 20260508
Ramaco Resources METC Competitive Landscape Q4 2025 EPS Beats Forecasts
Why Adamas Trust ADAMZ ability to execute stands out 036 20260505
What Wall Street expects from Rigetti Computing RGTI this quarter Q4 2025 EPS Beats Forecasts